About Us Contact Us Disclaimer Sitemap
  New Old
HOME TRADING DERIVATIVES PMS MUTUAL FUNDS IPO BONDS RESEARCH MARKET
left «« +1 «« -1 right
 
  Equity Analysis
  Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
  Volume
  Analysis
  News Analysis
Corporate Action
  Corporate Info
  Other Market
 
Company News  
 
Cipla Ltd.
Change Company   
BSE Code 500087
ISIN Demat INE059A01026
Book Value(Rs.) 186.99
NSE Code CIPLA
Dividend Yield % 0.53
Market Cap(Rs. in millions) 458002.03
P/E 30.96
EPS 18.36
Face Value(Rs.) 2  
23-Apr-2019 Announcement under Regulation 30 (LODR)-Press Re...
18-Apr-2019 Announcement under Regulation 30 (LODR)-Allotmen...
17-Apr-2019 Cipla’s arm to acquire 30% stake in Brandmed
16-Apr-2019 Announcement under Regulation 30 (LODR)-Acquisit...
16-Apr-2019 Cipla’s arm inks definitive agreement with Pulmat...
16-Apr-2019 Cipla rises with its arm inking definitive agreem...
16-Apr-2019 Dr. Reddys Lab, Majesco and Cipla to see some act...
15-Apr-2019 Update On The Transaction With Pulmatrix Inc. By...
12-Apr-2019 Announcement under Regulation 30 (LODR)-Press Re...
12-Apr-2019 Cipla launches Niveoli HFA inhaler for adults
12-Apr-2019 Cipla gains on launching Niveoli HFA inhaler for ...
12-Apr-2019 Cipla submits press release
05-Apr-2019 Announcement under Regulation 30 (LODR)-Code of ...
05-Apr-2019 Cipla gets EIR from USFDA for facility at Goa
05-Apr-2019 Cipla spurts on getting EIR from USFDA for facili...
Page 1 of 6
Prev || Next
 
Terms & Conditions Copyright ©ATLAS All rights reserved. Designed || Developed & Content Powered By Accord Fintech Pvt.Ltd.

Important Links : SEBI | NSE | BSE | RBI | CDSL | NSDL | Investor Grievance| Policy
SEBI REG. NO. NSE : CASH INB230956935; FO INF230956935; CURRENCY INE230956935 | BSE : CASH INB010956937; FO INF010956937
PMS : INP000000530 | AMFI : ARN0770 | CDSL : IN-DP-CDSL-465-2008